The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksUpdated×2•Originally published 14 April 2026•Updated 14 April 2026•

1 min read

Abbott Laboratories Acquires Exact Sciences Amid Stock Decline and Mixed Earnings

A man in a suit with a large British Pound symbol, UK flag, Bank of England, London skyline, financial charts, and pound coins.

Key Facts

1Hormel Foods (HRL) maintains an attractive dividend yield of 5.45%.

2FY26 guidance targets net sales of $12.2–$12.5 billion and organic growth of 1–4%.

3Adjusted EPS for FY26 is projected to be between $1.43 and $1.51.

about 2 months ago

Version History

Version 2about 2 months ago

What changed: The story was updated to focus on Abbott Laboratories (ABT), highlighting a 16% share price decline, the acquisition of Exact Sciences, and mixed segment performance in recent earnings.

Version 1about 2 months ago

What changed: The story was updated to include historical price performance (46% five-year decline) and new valuation metrics, including DCF intrinsic value analysis and P/E ratio comparisons against industry averages.

Abbott Laboratories (ABT) shares have declined by over 16% since the previous analyst review, reflecting increased volatility in its market valuation. In a strategic move to strengthen its business portfolio, the healthcare giant has acquired Exact Sciences, aiming to integrate new diagnostic capabilities. This acquisition follows the company's most recent earnings report, which revealed mixed performance across its various business segments. While some divisions showed resilience, others faced headwinds that contributed to the overall neutral-to-bearish sentiment. Analysts are now focusing on whether the synergy from the Exact Sciences deal can offset recent price pressures and stabilize long-term growth.